David Callanan

5.9k total citations
69 papers, 3.0k citations indexed

About

David Callanan is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, David Callanan has authored 69 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Ophthalmology, 26 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in David Callanan's work include Retinal Diseases and Treatments (36 papers), Retinal and Optic Conditions (27 papers) and Ocular Diseases and Behçet’s Syndrome (25 papers). David Callanan is often cited by papers focused on Retinal Diseases and Treatments (36 papers), Retinal and Optic Conditions (27 papers) and Ocular Diseases and Behçet’s Syndrome (25 papers). David Callanan collaborates with scholars based in United States, China and Spain. David Callanan's co-authors include Timothy L. Comstock, P. Andrew Pearson, Brian Levy, Daniel Martín, Glenn J. Jaffe, Daniel Martín, G. J. Jaffe, J S Peeler, J. Donald M. Gass and Patrick Williams and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Ophthalmology.

In The Last Decade

David Callanan

68 papers receiving 2.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Callanan 2.4k 1.1k 306 249 223 69 3.0k
Pravin U. Dugel 6.3k 2.6× 4.4k 3.9× 1.4k 4.5× 204 0.8× 222 1.0× 151 7.1k
Raja Narayanan 2.1k 0.9× 1.3k 1.2× 481 1.6× 164 0.7× 89 0.4× 184 2.5k
Frederick H. Davidorf 1.4k 0.6× 373 0.3× 575 1.9× 52 0.2× 211 0.9× 85 2.0k
Donald U. Stone 457 0.2× 283 0.3× 159 0.5× 202 0.8× 131 0.6× 49 1.1k
L. A. Rozenszajn 305 0.1× 214 0.2× 380 1.2× 106 0.4× 694 3.1× 65 1.8k
Bryan K. Rutledge 477 0.2× 292 0.3× 150 0.5× 23 0.1× 207 0.9× 13 876
Jong‐Baeck Lim 234 0.1× 179 0.2× 415 1.4× 36 0.1× 488 2.2× 62 1.5k
Denise Hileeto 194 0.1× 217 0.2× 169 0.6× 142 0.6× 36 0.2× 34 813
Shinichi Sasaki 150 0.1× 86 0.1× 266 0.9× 74 0.3× 123 0.6× 81 1.2k
Herbert B. Lindsley 37 0.0× 228 0.2× 143 0.5× 66 0.3× 287 1.3× 23 861

Countries citing papers authored by David Callanan

Since Specialization
Citations

This map shows the geographic impact of David Callanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Callanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Callanan more than expected).

Fields of papers citing papers by David Callanan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Callanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Callanan. The network helps show where David Callanan may publish in the future.

Co-authorship network of co-authors of David Callanan

This figure shows the co-authorship network connecting the top 25 collaborators of David Callanan. A scholar is included among the top collaborators of David Callanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Callanan. David Callanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Krishnan, Anitha, Jutamas Shaughnessy, Sanjay Ram, et al.. (2024). PolySialic Acid Nanoparticles Actuate Complement-Factor-H-Mediated Inhibition of the Alternative Complement Pathway: A Safer Potential Therapy for Age-Related Macular Degeneration. Pharmaceuticals. 17(4). 517–517. 6 indexed citations
3.
Callanan, David, Rahul N. Khurana, Raj K. Maturi, et al.. (2023). Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results. Clinical ophthalmology. Volume 17. 1367–1384. 6 indexed citations
4.
Callanan, David, Derek Kunimoto, Raj K. Maturi, et al.. (2018). Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration. Journal of Ocular Pharmacology and Therapeutics. 34(10). 700–709. 55 indexed citations
5.
Itty, Sujit, et al.. (2015). Spontaneous Dislocation of Fluocinolone Acetonide Implant Pellets From Their Suture Struts. American Journal of Ophthalmology. 159(5). 868–876.e1. 6 indexed citations
6.
Diana, V., Peter A. Campochiaro, David S. Boyer, et al.. (2012). 6 Month Results of the READ 3 Study: Ranibizumab for Edema of the mAcula in Diabetes. Investigative Ophthalmology & Visual Science. 53(14). 5282–5282. 1 indexed citations
7.
Stalmans, Ingeborg, David Callanan, Monte S. Dirks, et al.. (2012). Treatment of Steroid-Induced Elevated Intraocular Pressure with Anecortave Acetate: A Randomized Clinical Trial. Journal of Ocular Pharmacology and Therapeutics. 28(6). 559–565. 5 indexed citations
8.
Kurup, Shree K., et al.. (2012). LOW-DOSE METHOTREXATE FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Retina. 32(10). 2096–2101. 17 indexed citations
9.
10.
Jamal, Karim & David Callanan. (2009). The role of difluprednate ophthalmic emulsion in clinical practice. SHILAP Revista de lepidopterología. 10 indexed citations
11.
Callanan, David, et al.. (2008). Topical nepafenac in the treatment of diabetic macular edema. SHILAP Revista de lepidopterología. 6 indexed citations
12.
Callanan, David, et al.. (2008). Clinical Evaluation of the Safety and Efficacy of TRIESENCETM (Triamcinolone Acetonide Injectable Suspension) 40 mg/mL for Visualization of Vitreous and Membranes in Pars Plana Vitrectomy. Investigative Ophthalmology & Visual Science. 49(13). 5601–5601. 1 indexed citations
13.
Hariprasad, Seenu M., et al.. (2007). Cystoid and Diabetic Macular Edema Treated with Nepafenac 0.1%. Journal of Ocular Pharmacology and Therapeutics. 23(6). 585–590. 44 indexed citations
14.
Jaffe, Glenn J., Daniel Martín, David Callanan, Brian Levy, & Timothy L. Comstock. (2006). Fluocinolone Acetonide Intravitreal Implant to Treat Posterior Segment Uveitis: 3–Year Results of a Multi–Center Clinical Trial. Investigative Ophthalmology & Visual Science. 47(13). 1523–1523. 4 indexed citations
15.
Callanan, David, et al.. (2006). Early Onset Endophthalmitis Caused by Aspergillus Species Following Cataract Surgery. American Journal of Ophthalmology. 142(3). 509–511. 20 indexed citations
16.
Jaffe, Glenn J., Daniel Martín, David Callanan, & Brian Levy. (2005). Fluocinolone Acetonide Intravitreal Implant to Treat Posterior Uveitis: 2–year Results of a Multi–Center Clinical Trial. Investigative Ophthalmology & Visual Science. 46(13). 2386–2386. 5 indexed citations
17.
Pearson, P. Andrew, Carl W. Baker, Dean Eliott, et al.. (2003). Fluocinolone Acetonide Intravitreal Implant in Patients with Diabetic Macular Edema: 12 Month Results. Investigative Ophthalmology & Visual Science. 44(13). 4288–4288. 4 indexed citations
18.
Busquets, Miguel, Gaurav K. Shah, David Callanan, et al.. (2003). OCULAR PHOTODYNAMIC THERAPY WITH VERTEPORFIN FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO OCULAR HISTOPLASMOSIS SYNDROME. Retina. 23(3). 299–306. 30 indexed citations
19.
Callanan, David. (1993). Choroidal Neovascularization Associated With Choroidal Nevi. Archives of Ophthalmology. 111(6). 789–789. 30 indexed citations
20.
Peeler, J S, David Callanan, Martha W. Luckenbach, & Jérry Y. Niederkorn. (1988). Presentation of the H-Y antigen on Langerhans' cell-negative corneal grafts downregulates the cytotoxic T cell response and converts responder strain mice into phenotypic nonresponders.. The Journal of Experimental Medicine. 168(5). 1749–1766. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pravin U. Dugel Breakdown of academic impact, for papers by Raja Narayanan Breakdown of academic impact, for papers by Frederick H. Davidorf Breakdown of academic impact, for papers by Donald U. Stone Breakdown of academic impact, for papers by L. A. Rozenszajn Breakdown of academic impact, for papers by Bryan K. Rutledge Breakdown of academic impact, for papers by Jong‐Baeck Lim Breakdown of academic impact, for papers by Denise Hileeto Breakdown of academic impact, for papers by Shinichi Sasaki Breakdown of academic impact, for papers by Herbert B. Lindsley
Rankless by CCL
2026